Amphetamine use and its correlates among youths living with HIV.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Amphetamine use and its correlates among youths living with HIV.

AIDS Educ Prev. 1999 Jun;11(3):232-42. Unique Identifier : AIDSLINE MED/99335772
Rotheram-Borus MJ; Mann T; Chabon B; Department of Psychiatry, University of California, Los Angeles,; USA.

Abstract: Amphetamine use and its correlates are examined among youths living with HIV (YLH) to determine whether its use is associated with increased transmission acts and poor health. Amphetamine use, other HIV-related risk acts, T-cell counts, emotional distress, coping style, and symptoms of HIV are examined in 337 YLH. One third of YLH engaged in amphetamine use in their lifetime, and 21% of youths reported current use (i.e., in the last 3 months). Compared with those who never used, users initiated other drug use at younger ages, used more types of drugs, reported more emotional distress, and employed escape coping significantly more often. Compared with those who have never used (never-users), users also had more sexual partners and more sexual encounters. Although users and never-users do not differ on physical symptoms or whether they have been diagnosed with AIDS, users of amphetamines report significantly higher T-cell counts than never-users. Despite poor psychosocial functioning, amphetamine users have higher T-cell counts than other YLH; future research must examine longitudinally if a quadratic relationship exists between amphetamine use and health status. The continued high-risk profile of transmission acts among users suggests that preventive interventions must target specific drugs used by YLH.

Keywords: JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY Adaptation, Psychological Adolescence Adult *Amphetamines Comparative Study Emotions Ethnic Groups Female Health Status Heterosexuality Homosexuality Homosexuality, Female Human *HIV Infections/EPIDEMIOLOGY HIV Seropositivity/EPIDEMIOLOGY Male Questionnaires Risk Factors Sex Factors Substance-Related Disorders/*COMPLICATIONS/PSYCHOLOGY Support, U.S. Gov't, P.H.S.
991130
A99B1073

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .